CYAD
Celyad Oncology SA American Depositary Shares
CYAD
CYAD
Delisted
CYAD was delisted on the 18th of May, 2023.
4 hedge funds and large institutions have $16M invested in Celyad Oncology SA American Depositary Shares in 2017 Q2 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$35.7K |
| 2 |
Morgan Stanley
New York
|
+$16.9K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Victory Capital Management
San Antonio,
Texas
| $15.8M | -$80.6K | -1,901 | -0.5% |
|
|
2
Morgan Stanley
New York
| $150K | +$16.9K | +400 | +13% |
|
|
3
UBS Group
Zurich,
Switzerland
| $53K | +$35.7K | +846 | +206% |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $1K | -$16.9K | -337 | -94% |
|
|
DCM
5
DAFNA Capital Management
Los Angeles,
California
| – | -$328K | -12,528 | Closed |
|
6
Zurich Cantonal Bank
Zurich,
Switzerland
| – | -$42K | -1,560 | Closed |
|